Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

[Why complete or partial response can not be achieved by immunotherapy].

S Fujimoto1, K Nitta

  • 1Division of Chemotherapy, Chiba Cancer Center Research Institute.

Gan to Kagaku Ryoho. Cancer & Chemotherapy
|March 1, 1990
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Formation and evolution of carbonaceous asteroid Ryugu: Direct evidence from returned samples.

Science (New York, N.Y.)·2022
Same author

Case report: Electron microscopic evaluation of bone from a patient treated with cinacalcet hydrochloride, maxacalcitol, and alfacalcidol for hyperparathyroid bone disease with secondary hyperparathyroidism.

Osteoporosis international : a journal established as result of cooperation between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the USA·2018
Same author

Glycaemic control boosts glucosylated nanocarrier crossing the BBB into the brain.

Nature communications·2017
Same author

Associations between the levels of sclerostin, phosphate, and fibroblast growth factor-23 and treatment with vitamin D in hemodialysis patients with low intact PTH level.

Osteoporosis international : a journal established as result of cooperation between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the USA·2014
Same author

Sarkomycin, and anti-cancer substance produced by Stroptomyces.

Antibiotics & chemotherapy (Northfield, Ill.)·2014
Same author

Sialyl-glycoconjugates in cholesterol-rich microdomains of P388 cells are the triggers for apoptosis induced by Rana catesbeiana oocyte ribonuclease.

Glycoconjugate journal·2013
Same journal

[A Case of Pulmonary Epithelioid Hemangioendothelioma Associated with Multiple Cancers].

Gan to kagaku ryoho. Cancer & chemotherapy·2026
Same journal

[Long-Term Survival in Three Cases with Pulmonary Metastases from Colorectal Cancer Given Low-Dose S-1 Under a Regimen Combining a Carbohydrate-Restricted Ketogenic Diet, Metformin, Vitamin D, Eicosapentaenoic Acid, and Other Complementary Therapies].

Gan to kagaku ryoho. Cancer & chemotherapy·2026
Same journal

[Preventive Effect of Saline Eye Wash for Eye Symptoms Due to High-Dose and Intermediate-Dose Cytarabine Therapy].

Gan to kagaku ryoho. Cancer & chemotherapy·2026
Same journal

[Examination of Factors Affecting the Efficacy of Naldemedine Tosilate Tablets for Opioid-Induced Constipation].

Gan to kagaku ryoho. Cancer & chemotherapy·2026
Same journal

[Recent Advances in the Treatment of HER2-Altered Solid Tumors].

Gan to kagaku ryoho. Cancer & chemotherapy·2026
Same journal

[BRAF-Mutant Solid Tumor].

Gan to kagaku ryoho. Cancer & chemotherapy·2026
See all related articles

Immunotherapy may not shrink tumors but is effective by killing a constant number of cells. It plays a crucial role in combined cancer treatment, especially when chemotherapy resistance is a concern.

Area of Science:

  • Oncology
  • Immunology
  • Cancer Research

Context:

  • Chemotherapy effectively reduces tumor mass via fractional cell kill, achieving partial or complete responses.
  • Immunotherapy's mechanism involves constant number cell kill, which may not lead to significant tumor shrinkage.
  • Residual tumor cells post-surgery can develop drug resistance, posing a challenge in cancer treatment.

Purpose:

  • To evaluate the effectiveness of immunotherapy in cancer treatment beyond tumor mass reduction.
  • To understand the distinct cytocidal action of immunotherapy compared to chemotherapy.
  • To highlight the importance of immunotherapy in combination therapy, considering chemotherapy resistance.

Summary:

  • Tumor mass shrinkage is difficult with immunotherapy alone, but its constant cell kill mechanism is valuable.

Related Experiment Videos

  • Disease-free survival curves suggest logarithmic reduction of tumor burden even in non-responders to adjuvant chemotherapy.
  • The potential for residual tumor cells to develop drug resistance underscores immunotherapy's role.

    • Impact:

    • Immunotherapy's role in combined modality cancer treatment is critical, even if it doesn't achieve immediate tumor shrinkage.
    • Understanding immunotherapy's unique cell kill dynamics can optimize combination treatment strategies.
    • This research supports the integration of immunotherapy to overcome chemotherapy resistance and improve patient outcomes.